ARS Pharmaceuticals Stock Quote SPRY - Stock Price, News, Charts, Message Board, Trades

Q: What is the current ARS Pharmaceuticals share price?

The current share price of ARS Pharmaceuticals is $ 15.35

Q: How many ARS Pharmaceuticals shares are in issue?

ARS Pharmaceuticals has 98,213,561 shares in issue

Q: What is the market cap of ARS Pharmaceuticals?

The market capitalisation of ARS Pharmaceuticals is USD 1.41B

Q: What is the 1 year trading range for ARS Pharmaceuticals share price?

ARS Pharmaceuticals has traded in the range of $ 7.55 to $ 18.49 during the past year

Q: What is the PE ratio of ARS Pharmaceuticals?

The price to earnings ratio of ARS Pharmaceuticals is 189.19

Q: What is the cash to sales ratio of ARS Pharmaceuticals?

The cash to sales ratio of ARS Pharmaceuticals is 16.97

Q: What is the reporting currency for ARS Pharmaceuticals?

ARS Pharmaceuticals reports financial results in USD

Q: What is the latest annual turnover for ARS Pharmaceuticals?

The latest annual turnover of ARS Pharmaceuticals is USD 89.15M

Q: What is the latest annual profit for ARS Pharmaceuticals?

The latest annual profit of ARS Pharmaceuticals is USD 8M

Q: What is the registered address of ARS Pharmaceuticals?

The registered address for ARS Pharmaceuticals is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

15.35

Bid

15.40

Ask

15.50

Volume

1,171,007

14.15 Day's Range 15.43

7.55 52 Week Range 18.49

Market Cap

1.508B

Previous Close

14.40

Open

14.15

Last Trade

15.4

Last Trade Time

Financial Volume

$ 17,625,733

VWAP

15.0518

Average Volume (3m)

1,586,071

Shares Outstanding

98,213,561

Dividend Yield

PE Ratio

189.19

Earnings Per Share (EPS)

0.08

Revenue

89.15M

Net Profit

ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for pa... ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

ars-pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

ARS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SPRY. The last closing price for ARS Pharmaceuticals was $14.40. Over the last year, ARS Pharmaceuticals shares have traded in a share price range of $ 7.55 to $ 18.49.

ARS Pharmaceuticals currently has 98,213,561 shares outstanding. The market capitalization of ARS Pharmaceuticals is $1.41 billion. ARS Pharmaceuticals has a price to earnings ratio (PE ratio) of 189.19.

Overall Flow

Bearish

Net Premium

-67k

Calls / Puts

0.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences

SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

ARS Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Progress in U.S. Commercial Launch of neffy® (epinephrine nasal spray)

$7.8 million in total neffy U.S. net product revenue in first quarter of 2025 neffy 1 mg available nationwide...

ARS Pharmaceuticals’ neffy® (epinephrine nasal spray) 1 mg is Now Available in the United States for Type I Allergic Reactions, including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms

The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of...

ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2025 Financial Results

SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical...

Form 8-K - Current report

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians

Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.68	12.2896854426	13.67	15.49	13.5401	806821	14.4937013	CS
4	2.95	23.7903225806	12.4	15.5	12.4	1238423	14.41602396	CS
12	1.665	12.1666057727	13.685	15.5	11.65	1586071	13.59492792	CS
26	2.69	21.2480252765	12.66	15.5	10.01	1503908	12.77716081	CS
52	6.25	68.6813186813	9.1	18.49	7.55	1274206	12.90245214	CS
156	10.07	190.71969697	5.28	18.49	2.55	866424	10.0170356	CS
260	10.07	190.71969697	5.28	18.49	2.55	866424	10.0170356	CS

SPRY - Frequently Asked Questions (FAQ)

What is the current ARS Pharmaceuticals share price?

The current share price of ARS Pharmaceuticals is $ 15.35

How many ARS Pharmaceuticals shares are in issue?

ARS Pharmaceuticals has 98,213,561 shares in issue

What is the market cap of ARS Pharmaceuticals?

The market capitalisation of ARS Pharmaceuticals is USD 1.41B

What is the 1 year trading range for ARS Pharmaceuticals share price?

ARS Pharmaceuticals has traded in the range of $ 7.55 to $ 18.49 during the past year

What is the PE ratio of ARS Pharmaceuticals?

The price to earnings ratio of ARS Pharmaceuticals is 189.19

What is the cash to sales ratio of ARS Pharmaceuticals?

The cash to sales ratio of ARS Pharmaceuticals is 16.97

What is the reporting currency for ARS Pharmaceuticals?

ARS Pharmaceuticals reports financial results in USD

What is the latest annual turnover for ARS Pharmaceuticals?

The latest annual turnover of ARS Pharmaceuticals is USD 89.15M

What is the latest annual profit for ARS Pharmaceuticals?

The latest annual profit of ARS Pharmaceuticals is USD 8M

What is the registered address of ARS Pharmaceuticals?

The registered address for ARS Pharmaceuticals is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801

What is the ARS Pharmaceuticals website address?

The website address for ARS Pharmaceuticals is ars-pharma.com

Which industry sector does ARS Pharmaceuticals operate in?

ARS Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RBNERobin Energy Ltd	$ 13.85 (313.43%)	101.81M
OPOceanPal Inc	$ 1.63 (125.45%)	80.28M
LGHLWLion Group Holding Ltd	$ 0.0052 (116.67%)	6.87M
NEONNeonode Inc	$ 16.83 (68.47%)	4.78M
ICONIcon Energy Corporation	$ 2.90 (62.01%)	59.04M
SBETSharpLink Gaming Inc	$ 9.2275 (-71.63%)	41.92M
AIHSSenmiao Technology Ltd	$ 0.381 (-63.01%)	16.8M
CHSNChanson International Holding	$ 0.22 (-60.00%)	15.15M
KWMK Wave Media Ltd	$ 2.91 (-50.43%)	2.59M
JZXNJiuzi Holdings Inc	$ 1.56 (-46.39%)	2.24M
HCTIHealthcare Triangle Inc	$ 0.0201 (-33.00%)	856.89M
GNLNGreenlane Holdings Inc	$ 0.0101 (-34.42%)	792.34M
CGBSCrown LNG Holdings Ltd	$ 0.1104 (31.43%)	788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.655 (3.81%)	246.13M
NVDANVIDIA Corporation	$ 141.97 (-2.09%)	180.81M